Loading memory…
Loading memory…
Patent portfolio assigned to Cellarity (verified via public assignee records). Cambridge, MA AI-driven drug design biotech, spun out of Flagship Pioneering. Novo Nordisk is a confirmed strategic R&D collaboration partner (MASH, up to $532M; confirmed via Novo Nordisk press). Cellarity Inc holds patents (assignee on Google Patents).